Total planned funding: $42,815,864
Allocations
Countries/Regions
| Central Asia Region | $42,815,864 |
Organizational Types
| Own Agency | $13,398,823 |
| University | $7,443,785 |
| NGO | $7,189,169 |
| Unknown | $6,805,987 |
| Host Country Government Agency | $4,157,871 |
| Private Contractor | $2,232,129 |
| Multi-lateral Agency | $1,240,000 |
| Other USG Agency | $181,100 |
| Implementing Agency | $167,000 |
Program Areas
| Prevention | $15,483,414 |
| Management and Operations | $10,842,145 |
| Governance and Systems | $9,030,488 |
| Treatment | $3,193,481 |
| Care | $2,405,245 |
| Testing | $1,861,091 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,983,701 |
| HVMS: Management and Operations | $10,842,145 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,473,151 |
| HLAB: Laboratory Infrastructure | $3,251,844 |
| OHSS: Health Systems Strengthening | $3,184,073 |
| HTXS: Treatment: Adult Treatment | $3,160,312 |
| HVSI: Strategic Information | $2,594,571 |
| HBHC: Care: Adult Care and Support | $2,282,630 |
| HVCT: Testing: HIV Testing and Counseling | $1,861,091 |
| HMBL: Biomedical Prevention: Blood Safety | $717,107 |
| HMIN: Biomedical Prevention: Injection Safety | $309,455 |
| HVTB: Care: TB/HIV | $122,615 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
USG Aggregated Agencies:
$7,621,823
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2017 | $1,400,000 |
Columbia University:
$7,443,785
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2012 | $979,042 |
| 2013 | $2,374,000 |
| 2017 | $3,163,000 |
Not Available:
$6,805,987
Countries/Regions
Central Asia Region
| 2011 | $1,092,788 |
| 2012 | $1,913,199 |
| 2013 | $3,800,000 |
Population Services International:
$5,312,378
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2012 | $0 |
| 2013 | $0 |
| 2017 | $2,001,384 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
| 2013 | $3,238,500 |